The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
This product will be manufactured at Lupin's Nagpur facility in India
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The inspection of the facility conducted from August 7 to August 11, 2023
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
With the establishment of five different precious metals alloy powder production methods
Subscribe To Our Newsletter & Stay Updated
